Jeroen van der Boon. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antineoplastic Agents/therapeutic useAtrasentanClinical Trials as TopicDisease ProgressionEndothelin-1/antagonists & inhibitorsHumansMaleProstatic Neoplasms/drug therapyPyrrolidines
Substances: See more » Antineoplastic AgentsEndothelin-1PyrrolidinesAtrasentan
Year: 2002 PMID: 12067675 DOI: 10.1016/s1470-2045(02)00704-0
Source DB: PubMed Journal: Lancet Oncol ISSN: 1470-2045 Impact factor: 41.316